Buy me a coffee
Home › FDA recalls › Xyvona
CLASS II · ModerateFDA

SUN PHARMACEUTICAL INDUSTRIES INC recalls Xyvona

📅 May 22, 2026 · 📍 Nationwide
Recalling company
SUN PHARMACEUTICAL INDUSTRIES INC
Product
Xyvona (levorphanol tartrate tablets), 2mg, 100 Tablets, Rx only, Forte BioPharma, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Fort Bio-Pharma, LLC., Las Vegas, NV 89113, NDC 72245-762-10
Reason
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
Classification
Class II – may cause temporary or medically reversible health consequences
Recall date
May 22, 2026
Reported
Jun 10, 2026
Distribution
Nationwide within the United States
Status
Ongoing
Lot / codes
Lot #: AD93852, Exp Date: 06/2027.
Company location
Princeton, NJ
Recall type
Voluntary: Firm initiated
Recall number
D-0598-2026
Agency
U.S. Food and Drug Administration (FDA)

View official FDA notice ↗ Search recall number D-0598-2026 in the FDA Enforcement Report. Also see FDA recall press releases.

If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.